Home › Mutual Funds › Nippon Mutual Fund › Nippon India Pharma Fund - Bonus
Latest NAV & returns of NIPPON INDIA PRIVATE LTD.

Nippon India Pharma Fund - Bonus

Add To Compare

previously known as Reliance Pharma Bns until

564.217 (1.205%)
NAV on July 03, 2026
Category Equity:
Sector - Healthcare
Investment StyleBox
Large Growth
Total Assets 8,636 cr
Turnover Ratio 14.27%
Expense Ratio 1.52%
Exit Load 1.00%if redeemed within
1 Months0.00%if redeemed after 1 Months
Returns
  • 1M: 6.39%
  • 1Y: 8.53%
  • 3M: 16.27%
  • 3Y: 21.47%
  • 6M: 10.14%
  • 5Y: 12.73%
Min Investment 5,000
ADDITIONAL INFO
Fund Manager Sailesh Raj Bhan (Since over 21 years) Kinjal Desai (Since about 8 years) Amber Singhania (Since 4 months)
ISIN INF204K01950
Fund Family Nippon
P/E Ratio 36.71
P/B Ratio 5.41
Launch Date June 05, 2004
Benchmark BSE Healthcare TR INR
ASSET ALLOCATION
EQUITY DISTRIBUTION
RISK MEASURES (3 yrs)
vs BSE Healthcare TR INR

Alpha -1.68
Beta 0.89
R-Squared 94.72
Info Ratio -1.04
Tracking Err 3.95
Sortino 1.535
Sharpe 0.908
Std Dev 15.221
Risk -
SECTOR WEIGHTINGS (%)
Financial 0.0%
Industrial 0.0%
Technology 0.0%
Basic Materials 0.0%
Consumer Cyclical 0.0%
Utilities Services 0.0%
Healthcare Services 100.00%
Energy Services 0.00%
Communication Services 0.00%
Consumer Defensive 0.00%
Real Estate 0.00%
INVESTMENT OBJECTIVE

The primary investment objective of the scheme is to seek to generate consistent returns by investing in equity and equity related or fixed income securities of Pharma and other associated companies.

View Factsheet
-
Best Sector Healthcare Funds
NAME LATEST
NAV		 RETURNS
1y     		FUND
ASSETS		 Expense
RATIO		 RISK
Sbi
SBI Healthcare Opportunities Fund Direct Growth
573.761 16.05% 4,566 cr 0.91% -


Other plans of Nippon India Pharma


Other Equity funds by Nippon

Data Partner
Click here to visit AMC website and
read all scheme related documents Nippon Fund